VisualMED Clinical Solutions Corp. (The "Company") (PINKSHEETS: VMCS) (FRANKFURT: VA6) announces that following President Obama's re-election and a Democrat controlled Senate blocking attempts to roll back healthcare reform, the Company expects to see major growth in the sales and deployments of its business lines. This is backed by a clear political mandate for the White House to continue major reform programs in the U.S. healthcare sector over the next 4 years.

VisualMED believes that its prospects have been buoyed by this election, with Democratic initiatives in healthcare promising to speed up the deployment of our most advanced solutions and validate our current business model.

The Company expects an immediate expansion of its Transitional Care solutions across many healthcare jurisdictions involving its powerful public/private partnership with the Government of Maryland and the University of Maryland. Pilot projects are in place for Transitional Care which until now has been completely neglected, leaving a void in the care process which the Administration intends to remedy. The Company has been working on Transitional Care for years and is almost alone in the marketplace to offer validated instruments in this completely new segment of the healthcare delivery process, valued in the near term in the tens of billions in the U.S. alone.

The Administration's commitment to provide better care for its veterans will also give a major boost to our mobile medical solutions which we have been developing in the past year. The mobile tracking solutions we currently offer through our joint venture with the State of Maryland, Intelaform and Verizon could greatly enhance remote location support for Veterans and therefore offer better care more efficiently, saving expense without cutting short-term acute care. This is the latest in patient tracking, improving medical outcomes, whose potential value in terms of revenue to the Company and its partners cannot be overestimated in this trillion dollar industry where everything must now change.

Also on track is VisualMED's private/public partnership for a National Emergency Preparedness Response program designed to provide medical support in real time to first responders at the scene of a natural disaster. National Emergency Preparedness has become a major priority at all levels of government, because of the threat of bio-terrorism and natural catastrophes.

All of these initiatives bring immediate expansion of the VisualMED brand and the line of products it provides. Increased funding and subsidies of new healthcare processes and technologies by the Federal Government are designed to force the medical industry to become more cost efficient while at the same time increasing the quality of care for patients.

About VisualMED VisualMED markets advanced Clinical Information Systems (CIS) and Computerized Physician Order Entry that meet the new regulatory environment ushered in by the American Recovery and Reinvestment Act of 2009 and the Health Reform Act of 2010. VisualMED offers a powerful technology platform both scalable and interoperable, developed at a cost of some $40 million and tested over many years in tertiary care and ambulatory environments. It's also a main driver of mobile solutions to provide better home care alternatives for patients and seniors. VisualMED solutions help health care agencies reduce mortality and morbidity due to medical errors, increase provider efficiency, and bring down operating costs. The key clinical components are a core solution in the new agenda to promote greater patient safety and reduce risks due to medication errors. The Company's Suites of Medical Solutions operate on state of the art proprietary software platforms with advanced analytical capabilities provided by Visual Healthcare Corp. (PINKSHEETS: VSHC).

Detailed information on our company and its products is available on our web site at www.visualmedsolutions.com

FORWARD-LOOKING STATEMENTS Except for historical information provided herein, this press release may contain information and statements of a forward-looking nature concerning the future performance of the Company. These statements are based on suppositions and uncertainties as well as on management's best possible evaluation of future events. Such factors may include, without excluding other considerations, fluctuations in quarterly results, evolution in customer demand for the Company's products and services, the impact of price pressures exerted by competitors, and general market trends or economic changes. As a result, readers are advised that actual results may differ from expected results.

For further information, please contact: Gerard Dab 514-582-5220

VisualMED Clinical Solut... (PK) (USOTC:VMCS)
Historical Stock Chart
From May 2024 to Jun 2024 Click Here for more VisualMED Clinical Solut... (PK) Charts.
VisualMED Clinical Solut... (PK) (USOTC:VMCS)
Historical Stock Chart
From Jun 2023 to Jun 2024 Click Here for more VisualMED Clinical Solut... (PK) Charts.